Beatriz Rezende

Beatriz Rezende

Auto-generated profile, based on publicly available information

Beatriz Rezende

Department of Biophysics and Pharmacology, Biosciences Institute of Botucatu, São Paulo State University, Botucatu, SP, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2025 in bioRxiv
Verified
Preprint
Open access
NMNoemia A. P. Mariani
Noemia A. P. Mariani
NSNatália C. M. Santos
Natália C. M. Santos
JAJuliana J. Andrade
Juliana J. Andrade
AAAlexandre D. Andrade
Alexandre D. Andrade
BRBeatriz Rezende
Beatriz Rezende
ESErick J.R. Silva
Erick J.R. Silva
Seminal plasma is essential for sperm survival and function after ejaculation. Semenogelin-1 (SEMG1), the predominant seminal plasma protein, transiently suppresses sperm motility and hyperactivation after ejaculation through epididymal protease inhibitor (EPPIN) binding. However, the molecular mechanism underlying SEMG1-mediated inhibition of hyperactivation remains unclear. Here, we tested the hypothesis that SEMG1 inhibits CatSper, a sperm-specific calcium channel crucial for hyperactivation. Full-length recombinant mouse SEMG1 (mSEMG1; Q32-G375) inhibited both progressive motility and hyperactivation; the latter was not recovered with NH 4 Cl-induced alkalinization, indicating an effect downstream of capacitation-associated intracellular alkalinization. Electrophysiological recordings revealed that mSEMG1 reduced CatSper currents at physiologically relevant concentrations. Truncated mSEMG1 fragments mSEMG1 Q32-V118 and mSEMG1 R98-G375 , but not mSEMG1 Y221-G375 , inhibited sperm hyperactivation and CatSper currents to a similar extent as full-length mSEMG1. Notably, only mSEMG1 R98-G375 retained full EPPIN-binding capacity. Together, our findings identify two functional domains within mSEMG1 (Q32-V118 and R98-S220) that inhibit sperm hyperactivation by suppressing CatSper activity and differ in their EPPIN-binding capacities. These functional domains represent promising prototypes for the design of spermiostatic molecules, offering additional avenues for non-hormonal male contraception. Summary statement: We report a novel mechanism by which SEMG1, a major seminal plasma protein, modulates sperm hyperactivation by inhibiting a key calcium channel, offering new insights into sperm function and non-hormonal male contraception.